Oral medication for moderate to severe atopic dermatitis
Treatments studied
Part of Immune system & allergy, Skin clinical trials.
This trial tests an oral medication (capsule) for moderate to severe atopic dermatitis (eczema) that has not responded well to other treatments. The goal is to see if it can reduce symptoms like itching and skin inflammation.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have had atopic dermatitis (eczema) for at least 1 year.
- Your eczema is moderate to severe, meaning it covers at least 10% of your body and you have frequent itching.
- You have not used certain experimental drugs or similar treatments for eczema before.
- You have not participated in another research study within the past 3 months.
- You are not pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an investigational oral tablet (VC005) for adults with moderate to severe atopic dermatitis (eczema). It is for people whose eczema has not been controlled well enough with topical treatments.
This trial tests an oral pill called LW402 for people with moderate-to-severe atopic dermatitis (eczema). It aims to see if the drug is safe and effective at reducing skin symptoms.
This study tests a new cream (CMS-D001) for people with moderate to severe eczema. Participants will receive either the study cream or a placebo (a cream with no active ingredient) to see if it helps reduce symptoms like itching and redness.
This study tests an oral medication (TLL-018) for people with moderate-to-severe atopic dermatitis (eczema) that hasn't been helped enough by topical treatments. The goal is to see if it can reduce symptoms like itching and skin inflammation.
This study tests an oral medication (EC-18) for moderate to severe atopic dermatitis (eczema) to see if it can improve symptoms like itching and skin rash. It may be an option for people whose eczema is not controlled by topical treatments.
This trial tests a new drug, QLS12010, to see if it is safe and how it works in healthy volunteers and in people with moderate to severe atopic dermatitis (eczema). It may offer a new treatment option for those whose eczema has not improved with topical creams.
Hear when a new Moderate to Severe Atopic Dermatitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.